Literature DB >> 32361293

Anti-inflammatory octahydroindolizine alkaloid enantiomers from Dendrobium crepidatum.

Yang Hu1, Hua Yang2, Xiaoqian Ding2, Jian Liu2, Xiachang Wang2, Lihong Hu3, Minyan Liu4, Chaofeng Zhang5.   

Abstract

Six pairs of octahydroindolizine-type alkaloid enantiomers (1-6) including three new compounds [(-)-1/(+)-1, 2] were isolated from the stems of Dendrobium crepidatum. Their structures including the absolute configurations were elucidated by extensive spectroscopic analyses and comparison between the experimental and calculated electronic circular dichroism (ECD). All compounds were examined for their inhibitory effects on nitric oxide (NO) production induced by lipopolysaccharide (LPS) in RAW264.7 cells. It was found that compounds (+)-1, 2 and (+)-6 exhibited pronounced inhibition on NO production with IC50 values in the range of 3.62-16.11 µM, being more active than the positive control, dexamethasone (IC50 = 47.04 µM). In vivo, compound 6 (100, 50 and 10 mg/kg) showed protective effects against LPS-induced acute lung injury (ALI) in mice.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Acute lung injury; Dendrobium crepidatum; Enantioselectivity; Indolizine-type alkaloids; Orchidaceae

Mesh:

Substances:

Year:  2020        PMID: 32361293     DOI: 10.1016/j.bioorg.2020.103809

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

Review 1.  Natural Composition and Biosynthetic Pathways of Alkaloids in Medicinal Dendrobium Species.

Authors:  Cheng Song; Jingbo Ma; Guohui Li; Haoyu Pan; Yanfang Zhu; Qing Jin; Yongping Cai; Bangxing Han
Journal:  Front Plant Sci       Date:  2022-05-06       Impact factor: 6.627

Review 2.  Traditional Uses and Pharmacologically Active Constituents of Dendrobium Plants for Dermatological Disorders: A Review.

Authors:  Yue-Hu Wang
Journal:  Nat Prod Bioprospect       Date:  2021-04-20

Review 3.  Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis.

Authors:  Bingfeng Lin; Pingcui Xu; Juan Zheng; Xuehui Deng; Qitao Ye; Zhongping Huang; Nani Wang
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.